Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Future of personalized medicine in oncology: a systems biology approach.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jun 2010

Gonzalez-Angulo Ana Maria, Hennessy Bryan T J, Mills Gordon B

Abstract excerpt

The development of cost-effective technologies able to comprehensively assess DNA, RNA, protein, and metabolites in patient tumors has fueled efforts to tailor medical care. Indeed validated molecular tests assessing tumor tissue or patient germline DNA already drive therapeutic decision making....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Combined Chemotherapy Protocols
Share to Clinical Trials as Topic
Share to Drug Delivery Systems

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Forecasting

Share to Pharmacogenetics

Share to Precision Medicine

Share to Proteomics

Share to Systems Biology

Source

Open in PubMed Open full text

Identifiers

PMID: 20406928
DOI: 10.1200/JCO.2009.27.0777
PMCID: PMC2881854

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20406928-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Future of personalized medicine in oncology: a systems biology approach.PMID 20406928Read ↗

Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.Semantic proximity Read ↗

Advancing Liver Cancer Treatment through Dynamic Genomics and Systems Biology: A Path Toward Personalized OncologySemantic proximity Read ↗

Personalized therapies in the cancer "omics" eraSemantic proximity Read ↗

From 'omics' to complex disease: a systems biology approach to gene-environment interactions in cancerSemantic proximity Read ↗

Multi-Omics Model Applied to Cancer Genetics.Semantic proximity Read ↗

Childhood cancers and systems medicine.Semantic proximity Read ↗

Systems Biology in Cancer Diagnosis Integrating Omics Technologies and Artificial Intelligence to support physician decision-makingSemantic proximity Read ↗

Systems medicine in colorectal cancer: from a mathematical model toward a new type of clinical trial.Semantic proximity Read ↗

Personalized Medicine and CancerSemantic proximity Read ↗

Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.Semantic proximity Read ↗

What lies beneath: looking beyond tumor genetics shows the complexity of signaling networks underlying drug sensitivity.Semantic proximity Read ↗

Systems biology approach for new target and biomarker identification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.